Hedge Fund - Redmile Group
Stoke Therapeutics Inc. (STOK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $63,781,440 | 3.85% | 4,721,054 | $13.50 |
| 2 | 2024 - Q1 (2024-03-31) | $68,486,162 | 2.51% | 5,073,049 | $6.06 |
| 3 | 2023 - Q4 (2023-12-31) | $13,810,162 | 0.49% | 2,625,506 | $4.27 |
| 4 | 2023 - Q3 (2023-09-30) | $15,258,422 | 0.72% | 3,872,696 | $6.58 |
| 5 | 2023 - Q2 (2023-06-30) | $42,043,648 | 1.61% | 3,955,188 | $10.64 |
| 6 | 2023 - Q1 (2023-03-31) | $34,531,149 | 1.49% | 4,145,396 | $9.02 |
| 7 | 2022 - Q4 (2022-12-31) | $5,929,629 | 0.24% | 642,430 | $10.40 |
| 8 | 2022 - Q3 (2022-09-30) | $10,732,000 | 0.41% | 835,830 | $15.94 |
| 9 | 2022 - Q2 (2022-06-30) | $26,331,000 | 1% | 1,993,268 | $15.19 |
| 10 | 2022 - Q1 (2022-03-31) | $42,613,000 | 1.33% | 2,024,368 | $20.03 |
| 11 | 2021 - Q4 (2021-12-31) | $53,898,000 | 1.22% | 2,246,668 | $23.86 |
| 12 | 2021 - Q3 (2021-09-30) | $60,597,000 | 1.05% | 2,381,958 | $27.88 |
| 13 | 2021 - Q2 (2021-06-30) | $82,755,000 | 1.22% | 2,458,558 | $35.35 |
| 14 | 2021 - Q1 (2021-03-31) | $98,811,000 | 1.39% | 2,544,062 | $56.93 |
| 15 | 2020 - Q4 (2020-12-31) | $166,358,000 | 2.01% | 2,686,234 | $45.84 |
| 16 | 2020 - Q3 (2020-09-30) | $85,383,000 | 1.56% | 2,549,506 | $28.55 |
| 17 | 2020 - Q2 (2020-06-30) | $59,630,000 | 1.1% | 2,502,306 | $23.74 |
| 18 | 2020 - Q1 (2020-03-31) | $49,600,000 | 1.39% | 2,165,938 | $24.71 |
| 19 | 2019 - Q4 (2019-12-31) | $28,908,000 | 0.69% | 1,020,778 | $25.15 |
| 20 | 2019 - Q3 (2019-09-30) | $21,866,000 | 0.73% | 1,017,478 | $27.89 |
| 21 | 2019 - Q2 (2019-06-30) | $29,806,000 | 0.84% | 1,021,808 | $26.85 |
The displayed share prices are average quarterly stock market prices.